| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248741 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/19/2001 | CA2190973C Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 06/19/2001 | CA2125964C Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/19/2001 | CA2095444C Fused pyrazine derivatives |
| 06/14/2001 | WO2001042243A2 Protein kinase inhibitors |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042227A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof |
| 06/14/2001 | WO2001042208A1 Cycloamine ccr5 receptor antagonists |
| 06/14/2001 | US20010003750 Used as research tools in pharmacological, diagnostic studies and treatment of diseases in mammals in which 1L-beta-protease activity is implicated; antiinflammatory agent |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/13/2001 | EP1106613A1 Uretedione derivative, curable resin composition comprising the same, and process for producing the same |
| 06/13/2001 | EP1106611A1 Crystalline or crystallized acid addition salt of losartan and purification method of losartan |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1105388A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 06/13/2001 | EP1105376A1 Oxindole derivatives as growth hormone releasers |
| 06/13/2001 | EP1105135A1 Antiviral indoleoxoacetyl piperazine derivatives |
| 06/13/2001 | EP1105124A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/13/2001 | EP0781279B1 Quinoxalinedione nmda receptor antagonists |
| 06/13/2001 | EP0741722B1 Triazole derivatives |
| 06/13/2001 | EP0666858B1 5-arylindole derivatives and their use as serotonin (5-ht 1) agonists |
| 06/13/2001 | EP0573667B1 Process for producing 4-substituted azetidinone derivative |
| 06/13/2001 | CN1299358A Heterocyclic Topoisomerase poisons |
| 06/13/2001 | CN1299351A Optically active substituted 2,4-diamino-1,3,5-triazines as herbicides |
| 06/13/2001 | CN1299347A Inhibitor of phospholipase enzymes |
| 06/13/2001 | CN1299346A Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 06/13/2001 | CN1067068C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 06/13/2001 | CN1067057C Serotonin 5-HI1A and dopamin D2 receptor ligands |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245799 [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| 06/12/2001 | US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/12/2001 | US6245770 Fungicidal pyrimidinones |
| 06/12/2001 | US6245768 Psychological disorders |
| 06/12/2001 | US6245761 Indolyl neuropeptide Y receptor antagonists |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | CA2019957C Heteroarylamino- and heteroaryloxypyridinamines and related compounds, a process for their preparation and their use as dermatological agents |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040198A2 Macrocyclic hydroxamic acid derivatives and their use as antimicrobial agents |
| 06/07/2001 | WO2001040194A1 Stilbene derivatives, their preparation and their use as antiviral agents |
| 06/07/2001 | WO2001040193A1 Method for the synthesis of pyrazolines |
| 06/07/2001 | WO2001040181A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | WO2001039773A1 Thrombopoietin mimetics |
| 06/07/2001 | WO2001039759A2 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 06/07/2001 | WO2001028493A3 Small molecule inhibitors of necrosis |
| 06/07/2001 | WO2001025213A3 Pyrrolo imidazole derivatives and their use as medicaments |
| 06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | CA2395094A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104407A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
| 06/06/2001 | EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 06/06/2001 | EP0781283B1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1066729C Benzimidazole derivatives, their producing process and its therapeutic use |
| 06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
| 06/06/2001 | CN1066726C 吡咯衍生物 Azole derivatives |
| 06/06/2001 | CN1066721C Novel tetrazolinones |
| 06/06/2001 | CN1066720C Process for producing pharmaceutically active CNS compounds |
| 06/06/2001 | CN1066719C Process for producing pharmaceutically active CNS compounds |
| 06/05/2001 | US6243102 Data-driven layout engine |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242612 Multistage reaction of forming pyrazoles as kinase and cox-2 enzyme inhibitors |
| 06/05/2001 | US6242475 Pesticidal 1-polyarylpyrazoles |
| 06/05/2001 | US6242455 Inhibiting a matrix metalloprotease associated disease |
| 06/05/2001 | US6242439 Azetidinone derivatives for the treatment of HCMV infections |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6241964 F-18 radiolabeled neurokinin-1 receptor antagonists |
| 06/05/2001 | CA2059647C Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038324A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038308A1 Novel 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 05/31/2001 | WO2001038304A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037835A1 Novel compounds |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | WO1999032454A9 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
| 05/31/2001 | CA2395564A1 Novel compounds |
| 05/31/2001 | CA2391575A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/30/2001 | EP1103551A1 Pyrazole derivatives and salts thereof |
| 05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
| 05/30/2001 | EP1103548A1 Triazolone derivatives, use thereof, and intermediate therefor |
| 05/30/2001 | EP1103243A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
| 05/30/2001 | EP1102782A1 Structural analogs of amine bases and nucleosides |
| 05/30/2001 | EP1102767A1 Substituted pyrazole derivatives |
| 05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/30/2001 | EP1102754A1 Imidazoles and related compounds as alpha-1a agonists |
| 05/30/2001 | EP1102753A2 Pyrazoles as estrogen receptor modulators |
| 05/30/2001 | EP1102752A1 Succinoylamino lactams as inhibitors of a beta protein production |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |